ClinicalTrials.Veeva

Menu

Evaluation of the Effectiveness of the Self-developed Pulmonary Lobar Ventilation Detector

C

China-Japan Friendship Hospital

Status

Enrolling

Conditions

Chronic Obstructive Pulmonary Disease

Treatments

Device: Self-developed pulmonary lobar ventilation detector
Device: Chartis detection system

Study type

Observational

Funder types

Other

Identifiers

NCT05799040
2022-NHLHCRF-LX-01-0202-3

Details and patient eligibility

About

The goal of observational study is to Evaluation of the effectiveness of the self-developed pulmonary lobar ventilation detector in Chronic Obstructive Pulmonary Disease. The main question it aims to answer are:Evaluation of the effectiveness of the self-developed pulmonary lobar ventilation detector.

Participants will use the self-developed pulmonary lobar ventilation detector and the imported Chartis detection system to evaluate the target pulmonary lobar collateral ventilation.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with chronic obstructive pulmonary disease who meet the GOLD diagnostic criteria
  • FEV1 ≤ 45% pred and FEV1/FVC<70%
  • TLC>100% pred and RV>175% pred
  • CAT≥18
  • >50% of emphysema destruction
  • Smoking prohibition>6 months
  • Sign the informed consent form

Exclusion criteria

  • PaCO2>8.0 kPa, or PaO2<6.0 kPa
  • 6-minute walking test<160m
  • Obvious chronic bronchitis, bronchiectasis or other infectious lung diseases
  • Three hospitalizations due to pulmonary infection in the past 12 months before the baseline assessment
  • Previous lobectomy, LVRS or lung transplantation
  • LVEF<45% and or RVSP>50mmHg
  • Anticoagulant therapy that cannot be stopped before surgery
  • The patient has obvious immune deficiency
  • Participated in other lung drug studies within 30 days before this study
  • Pulmonary nodules requiring intervention
  • Any disease or condition that interferes with the completion of the initial or subsequent assessment

Trial design

40 participants in 2 patient groups

Self-developed pulmonary lobar ventilation detector
Treatment:
Device: Self-developed pulmonary lobar ventilation detector
imported Chartis detection system
Treatment:
Device: Chartis detection system

Trial contacts and locations

1

Loading...

Central trial contact

Mingming Deng, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems